Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels

Journal of Bone and Mineral Metabolism

Volumn 24, Issue 4, 2006, Pages 300-306

  Kawata, Takehisa ^a,c   Imanishi, Yasuo ^a   Kobayashi, Keisuke ^a   Onoda, Naoyoshi ^a   Okuno, Senji ^b   Takemoto, Yoshiaki ^a   Komo, Takeshi ^a   Tahara, Hideki ^a   Wada, Michihito ^c   Nagano, Nobuo ^c   Ishimura, Eiji ^a   Miki, Takami ^a   Ishikawa, Tetsuro ^a   Inaba, Masaaki ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shirasagi Hospital   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

Calcimimetics; Calcium sensing receptor (CaR); Cinacalcet; Hyperparathyroidism; Parathyroid hormone (PTH); Vitamin D receptor (VDR)

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; CINACALCET; PARATHYROID HORMONE; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PARATHYROID CELL; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA;

HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERPARATHYROIDISM, SECONDARY; IMMUNOHISTOCHEMISTRY; NAPHTHALENES; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING;

EID: 33745620444     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-006-0687-y     Document Type: Article

References (22)

1. N Palanisamy Y Imanishi PH Rao H Tahara RS Chaganti A Arnold 1998 Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas J Clin Endocrinol Metab 83 5 1766 1770
2. Y Imanishi H Tahara N Palanisamy S Spitalny IB Salusky W Goodman ML Brandi TB Drueke E Sarfati P Urena RS Chaganti A Arnold 2002 Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia J Am Soc Nephrol 13 6 1490 1498
3. T Carling J Rastad E Szabo G Westin G Akerstrom 2000 Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism J Clin Endocrinol Metab 85 5 2000 2003
4. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism J Clin Endocrinol Metab 81 4 1598 1606
5. EM Brown G Gamba D Riccardi M Lombardi R Butters O Kifor A Sun MA Hediger J Lytton SC Hebert 1993 Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid Nature (Lond) 366 6455 575 580
6. Y Imanishi Y Hosokawa K Yoshimoto E Schipani S Mallya A Papanikolaou O Kifor T Tokura M Sablosky F Ledgard G Gronowicz TC Wang EV Schmidt C Hall EM Brown R Bronson A Arnold 2001 Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice J Clin Invest 107 9 1093 1102
7. EF Nemeth WH Heaton M Miller J Fox MF Balandrin BC Van Wagenen M Colloton W Karbon J Scherrer E Shatzen G Rishton S Scully M Qi R Harris D Lacey D Martin 2004 Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl J Pharmacol Exp Ther 308 2 627 635
8. DM Shoback JP Bilezikian SA Turner LC [tmp] McCary MD Guo M Peacock 2003 The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism J Clin Endocrinol Metab 88 12 5644 5649
9. M Peacock JP Bilezikian PS Klassen MD Guo SA Turner D Shoback 2004 Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism J Clin Endocrinol Metab 90 1 135 141
10. LD Quarles DJ Sherrard S Adler SJ Rosansky LC [tmp] McCary W Liu SA Turner DA Bushinsky 2003 The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease J Am Soc Nephrol 14 3 575 583
11. GA Block KJ Martin AL de Francisco SA Turner MM Avram 2004 Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 15 1516 1525
12. T Kawata Y Imanishi K Kobayashi T Kenko M Wada E Ishimura T Miki N Nagano M Inaba A Arnold Y Nishizawa 2005 Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism Eur J Endocrinol 153 4 587 594
13. JP Bilezikian JT Potts Jr H Fuleihan Gel M Kleerekoper R Neer M Peacock J Rastad SJ Silverberg R Udelsman SA Wells 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century J Clin Endocrinol Metab 87 12 5353 5361
14. K/DOQI Work Group chair G Shaul M Massry 2003 Clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 4 suppl 3 S1 S201
15. Y Imanishi M Inaba Y Nishizawa H Morii S Otani 1995 Involvement of polyamines in the proliferation of bovine parathyroid cells Miner Electrolyte Metab 21 1-3 197 200
16. 3 on bovine parathyroid cells J Steroid Biochem Mol Biol 70 4-6 243 248
17. SK Ganesh AG Stack NW Levin T Hulbert-Shearon FK Port 2001 Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 10 2131 2138
18. M Rodriguez F Caravaca E Fernandez MJ Borrego V Lorenzo J Cubero A Martin-Malo A Betriu AP Rodriguez AJ Felsenfeld 1997 Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism J Bone Miner Res 12 3 347 355
19. N Nagano EF Nemeth 2005 Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics J Pharmacol Sci 97 3 355 360
20. M Wada Y Furuya J Sakiyama N Kobayashi S Miyata H Ishii N Nagano 1997 The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor J Clin Invest 100 12 2977 2983
21. TB Drueke 2004 Modulation and action of the calcium-sensing receptor Nephrol Dial Transplant 19 suppl 5 V20 V26
22. M Mizobuchi I Hatamura H Ogata F Saji S Uda K Shiizaki T Sakaguchi S Negi E Kinugasa S Koshikawa T Akizawa 2004 Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency J Am Soc Nephrol 15 10 2579 2587